Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells
There is increasing evidence that hormones play an important role in the control of endothelial cell function and growth by regulating the production of vascular endothelial growth factor (VEGF). VEGF regulates vascular permeability and represents the most powerful growth factor for endothelial cell...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Society for Endocrinology
1999
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 14158caa a22011177a 4500 | ||
|---|---|---|---|
| 001 | PAPER-19630 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518205059.0 | ||
| 008 | 190411s1999 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-0242705311 | |
| 024 | 7 | |2 cas |a dexamethasone, 50-02-2; hypophysis adenylate cyclase activating polypeptide, 137061-48-4; mifepristone, 84371-65-3; vasculotropin, 127464-60-2 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a JOENA | ||
| 100 | 1 | |a Gloddek, J. | |
| 245 | 1 | 0 | |a Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells |
| 260 | |b Society for Endocrinology |c 1999 | ||
| 270 | 1 | 0 | |m Renner, U.; Max Planck Institute of Psychiatry, Department of Endocrinology, Kraepelinstr. 10, D-80804 Munich, Germany |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Allaerts, W., Carmeliet, P., Denef, C., New perspective's in the function of pituitary folliculo-stellate cells (1990) Molecular and Cellular Endocrinology, 71, pp. 73-81 | ||
| 504 | |a Arzt, E., Buric, R., Stelzer, G., Stalla, J., Sauer, J., Renner, U., Stalla, G.K., Interleukin involvement in anterior pituitary cell growth regulation: Effects of interleukin-2 (IL-2) and IL-6 (1993) Endocrinology, 132, pp. 459-467 | ||
| 504 | |a Banerjee, S.K., Sarkar, D.K., Weston, A.P., De, A., Campbell, D.R., Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-mitiated tumor angiogenesis (1997) Carcinogenesis, 18, pp. 1155-1161 | ||
| 504 | |a Berkman, R.A., Merrill, M.J., Reinhold, W.C., Monacci, W.T., Saxena, A., Clark, W.C., Robertson, J.T., Oldfleld, E.H., Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms (1993) Journal of Clinical Investigation, 91, pp. 153-159 | ||
| 504 | |a Carmeliet, P., Vankelecom, H., Van Damme, J., Billiau, A., Denef, C., Release of interleukin-6 from anterior pituitary cell aggregates: Developmental pattern and modulation by glucocorticoids and forskolin (1991) Neuroendocrinology, 53, pp. 29-34 | ||
| 504 | |a Claffey, K.P., Robinson, G.S., Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis (1996) Cancer Metastasis Reviews, 15, pp. 165-176 | ||
| 504 | |a Cohen, T., Nahari, D., Weiss Cerem, L., Neufeld, G., Levi, B.-Z., Interleukin 6 induces the expression of vascular endothelial growth factor (1996) Journal of Biological Chemistry, 271, pp. 736-741 | ||
| 504 | |a Cullinan-Bove, K., Koos, R.D., Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth (1993) Endocrinology, 133, pp. 829-837 | ||
| 504 | |a Dvorak, H.F., Brown, L.F., Detmar, M., Dvorak, A.M., Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis (1995) American Journal of Pathology, 146, pp. 1029-1039 | ||
| 504 | |a Farnoud, M.R., Kujas, M., Derome, P., Racadot, J., Peillon, F., Li, J.Y., Interactions between normal and tumoral tissues at the boundary of human anterior pituitary adenomas (1994) Virchows Archiv A, 424, pp. 75-82 | ||
| 504 | |a Ferrara, N., Henzel, W.J., Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothdial cells (1989) Biochemical and Biophysical Research Communications, 161, pp. 851-858 | ||
| 504 | |a Ferrara, N., Davis-Smyth, T., The biology of vascular endothelial growth factor (1997) Endocrine Reviews, 18, pp. 4-25 | ||
| 504 | |a Ferrara, N., Schweigerer, L., Neufeld, G., Mitchell, R., Gospodarowicz, D., Pituitary follicular cells produce basic tibroblast growth factor (1987) Proceedings of the National Academy of Sciences of the USA, 84, pp. 5773-5777 | ||
| 504 | |a Ferrara, N., Winer, J., Henzel, W.J., Pituitary follicular cells secrete an inhibitor of aortic endothelial tell growth: Identification as leukemia inhibitor factor (1992) Proceedings of the National Academy of Sciences of the USA, 89, pp. 698-702 | ||
| 504 | |a Heiss, J.D., Papavassiliou, E., Merill, M.J., Nieman, L., Knightly, J.J., Walbridge, S., Edwards, N.A., Oldfield, E.H., Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats (1996) Journal of Clinical Investigation, 98, pp. 1400-1408 | ||
| 504 | |a Inoue, K., Matsumoto, H., Koyama, C., Shibata, K., Nakazato, Y., Ito, A., Establishment of a folliculo-stellate-like cell line from a murine thyrotropic pituitary tumor (1992) Endocrinology, 131, pp. 3110-3116 | ||
| 504 | |a Jabbour, H.N., Boddy, S.C., Lincoln, G.A., Flt-1 in the ovine pituitary gland: Expression is independent of hypothalamic control (1997) Molecular and Cellular Endocrinology, 134, pp. 91-100 | ||
| 504 | |a Jones, T.H., Daniels, M., James, R.A., Justice, S.K., McCorkle, R., Price, A., Kendall-Taylor, P., Weetman, A.P., Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas (1994) Journal of Clinical Endocrinology and Metabolism, 78, pp. 180-187 | ||
| 504 | |a Kim, K., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H., Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo (1993) Nature, 362, pp. 841-844 | ||
| 504 | |a Klagsbrun, M., D'Amore, P.A., Vascular endothelial growth factor and its receptors (1996) Cytokine and Growth Factor Reviews, 7, pp. 259-270 | ||
| 504 | |a Koyama, C., Matsumoto, H., Sakai, T., Wakabayashi, K., Ito, A., Couch, E.F., Inoue, K., Pituitary folliculo-stellate-like cells stimulate somatotropic pituitary growth in nude mice (1995) Endocrine Pathology, 6, pp. 67-75 | ||
| 504 | |a Leung, D.W., Cachianes, G., Kuang, W.-J., Goeddel, D.V., Ferrara, N., Vascular endothelial growth factor is a secreted angiogenic mitogen (1989) Science, 246, pp. 1306-1309 | ||
| 504 | |a Mann, F., Kovacs, K., Stefaneanu, L., Horvath, E., Cheng, Z., S-100 protein immunopositivity in human nontumorous hypophyses and pituitary adenomas (1992) Endocrine Pathology, 3, pp. 28-38 | ||
| 504 | |a Matsumoto, H., Koyama, C., Sawada, T., Koike, K., Hirota, K., Miyake, A., Arimura, A., Inoue, K., Pituirary folliculo-stellate-like cell line (TtT/GF) responds to novel hypophysiotrophic peptidc (pituitary adenylate cyclase-activating peptide), showing increased adenosine 3′,5′-monophosphate and interleukin-6 secretion and cell proliferation (1993) Endocrinology, 133, pp. 2150-2155 | ||
| 504 | |a Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N.P., Risau, W., Ullrich, A., High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis (1993) Cell, 72, pp. 835-846 | ||
| 504 | |a Miyata, A., Arimura, A., Dahl, R., Minamino, N., Uehara, A., Jiang, L., Culler, M.D., Coy, D.H., Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells (1989) Biochemical and Biophysical Research Communications, 164, pp. 567-574 | ||
| 504 | |a Mustonen, T., Ahtalo, K., Endothelial receptor tyrosine kinases involved in angiogenesis (1995) Journal of Cell Biology, 129, pp. 895-898 | ||
| 504 | |a Nauck, M., Roth, M., Tamin, M., Eickelberg, O., Wieland, H., Stulz, P., Perruchoud, A.P., Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids (1997) American Journal of Respiratory Cell Molecular Biology, 16, pp. 398-406 | ||
| 504 | |a Rawlings, S.R., Hezareh, M., Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: Actions on the anterior pituitary gland (1996) Endocrine Reviews, 17, pp. 4-29 | ||
| 504 | |a Renner, U., Newton, C.J., Pagotto, U., Sauer, J., Arzt, E., Stalla, G.K., Involvement of interleukin-1 and interleukin-1 receptor antagonist in rat pituitary cell growth regulation (1995) Endocrinology, 136, pp. 3186-3193 | ||
| 504 | |a Renner, U., Gloddek, J., Arzt, E., Inoue, K., Stalla, G.K., Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells (1997) Experimental and Clinical Endocrinology and Diabetes, 105, pp. 345-352 | ||
| 504 | |a Rinehart, J.F., Farquhar, M.G., Electron microscopic studies of the anterior pituitary gland (1953) Journal of Histochemistry and Cytochemistry, 1, pp. 93-113 | ||
| 504 | |a Shifren, J.L., Tseng, J.F., Zaloudek, C.J., Ryan, I.P., Meng, Y.G., Ferrara, N., Jarfe, R.B., Taylor, K.N., Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis (1996) Journal of Clinical Endocrinology and Metabolism, 81, pp. 3112-3118 | ||
| 504 | |a Shweiki, D., Itin, A., Neufeld, G., Gitay-Goren, H., Keshet, E., Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis (1993) Journal of Clinical Investigation, 91, pp. 2235-2243 | ||
| 504 | |a Soh, E.Y., Sobhi, S.A., Wong, M.G., Meng, G., Siperstein, A.E., Clark, O.H., Duh, Q.-Y., Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines (1996) Surgery, 120, pp. 944-947 | ||
| 504 | |a Sone, H., Okuda, Y., Kawakami, Y., Kondo, S., Hanatani, M., Matsuo, K., Suzuki, H., Yamashita, K., Progesterone induces vascular endothelial growth factor on retinal pigment epithelial cells in culture (1996) Life Sciences, 59, pp. 21-25 | ||
| 504 | |a Ueta, Y., Levy, A., Chowdrey, H.S., Lightman, S.L., S-100 antigen-positive folliculostellate cells are not the source of IL-6 gene expression in human pituitary adenomas (1995) Journal of Neuroendocrinology, 7, pp. 467-474 | ||
| 504 | |a Vankelecom, H., Carmeliet, P., Van Damme, J., Billiau, A., Denef, C., Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system (1989) Neuroendocrinology, 49, pp. 102-106 | ||
| 504 | |a Wilting, J., Christ, B., Embryogenic angiogenesis: A review (1996) Naturwissenschaften, 83, pp. 153-164 | ||
| 520 | 3 | |a There is increasing evidence that hormones play an important role in the control of endothelial cell function and growth by regulating the production of vascular endothelial growth factor (VEGF). VEGF regulates vascular permeability and represents the most powerful growth factor for endothelial cells. In the normal anterior pituitary, VEGF has been detected only in folliculostellate (FS) cells. In the present study, the regulation of the release of VEGF from FS-like mouse TtT/GF cells, and from FS cells of rat pituitary monolayer cell cultures was investigated using a specific VEGF ELISA. Basal release of VEGF was demonstrated in cultures of both TtT/GF cells and rat pituitary cells. Interestingly, the VEGF secretion was stimulated by both forms of pituitary adenylate cyclase-activating polypeptide (PACAP-38 and PACAP-27), indicating that this hypothalamic peptide regulates endothelial cell function and growth within the pituitary. VEGF secretion was also stimulated by interleukin-6 (IL-6) whereas basal, IL- 6- and PACAP-stimulated secretion was inhibited by the synthetic glucocorticoid dexamethasone. The inhibitory action of dexamethasone was reversed by the glucocorticoid receptor antagonist RU486, suggesting that in FS cells functional glucocorticoid receptors mediate the inhibitory action of glucocorticoids on the VEGF secretion. The endocrine and auto-/paracrine control of VEGF production in pituitary FS cells by PACAP, IL-6 and glucocorticoids may play an important role both in angiogenesis and vascular permeability regulation within the pituitary under physiological and pathophysiological conditions. |l eng | |
| 593 | |a Lab. Fisiol. y Biologia Molecular, Univ. de Buenos Aires and CONICET, Ciudad Universitaria, 1428 Buenos Aires, Argentina | ||
| 593 | |a Max Planck Institute of Psychiatry, Department of Endocrinology, Kraepelinstr. 10, D-80804 Munich, Germany | ||
| 690 | 1 | 0 | |a DEXAMETHASONE |
| 690 | 1 | 0 | |a GLUCOCORTICOID |
| 690 | 1 | 0 | |a HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE |
| 690 | 1 | 0 | |a INTERLEUKIN 6 |
| 690 | 1 | 0 | |a MIFEPRISTONE |
| 690 | 1 | 0 | |a VASCULOTROPIN |
| 690 | 1 | 0 | |a ANGIOGENESIS |
| 690 | 1 | 0 | |a ANIMAL CELL |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a BLOOD VESSEL PERMEABILITY |
| 690 | 1 | 0 | |a CELL FUNCTION |
| 690 | 1 | 0 | |a CELL GROWTH |
| 690 | 1 | 0 | |a ENDOTHELIUM CELL |
| 690 | 1 | 0 | |a HORMONAL REGULATION |
| 690 | 1 | 0 | |a HORMONE BLOOD LEVEL |
| 690 | 1 | 0 | |a HORMONE RELEASE |
| 690 | 1 | 0 | |a INHIBITION KINETICS |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a PROTEIN EXPRESSION |
| 690 | 1 | 0 | |a RAT |
| 690 | 1 | 0 | |a RECEPTOR UPREGULATION |
| 690 | 1 | 0 | |a REGULATORY MECHANISM |
| 700 | 1 | |a Pagotto, U. | |
| 700 | 1 | |a Paez Pereda, M. | |
| 700 | 1 | |a Arzt, E. | |
| 700 | 1 | |a Stalla, G.K. | |
| 700 | 1 | |a Renner, U. | |
| 773 | 0 | |d Society for Endocrinology, 1999 |g v. 160 |h pp. 483-490 |k n. 3 |p J. Endocrinol. |x 00220795 |t Journal of Endocrinology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0242705311&doi=10.1677%2fjoe.0.1600483&partnerID=40&md5=48866b9d43d1a7231e0714eae9f31fe8 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1677/joe.0.1600483 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_00220795_v160_n3_p483_Gloddek |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00220795_v160_n3_p483_Gloddek |y Registro en la Biblioteca Digital |
| 961 | |a paper_00220795_v160_n3_p483_Gloddek |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 80583 | ||